Does imaging modality influence DCIS recurrence?

Women who got ultrasound scans had lower rates of recurrence-free survival...Read more on AuntMinnie.comRelated Reading: Preop breast MRI improves DCIS surgical planning Contrast ultrasound can tell DCIS from fibroadenomas Breast MRI helps guide DCIS treatment Is radiation therapy warranted for DCIS postlumpectomy? Bilateral mastectomy not needed for DCIS
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Publication date: June 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 6Author(s): Erum Najeeb, Saed Ramzi, Maria Verroiotou, Claudiu Simonca, Stephanie Jenkins
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Publication date: June 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 6Author(s): Hedwige Nathaniel, Shahnaz Qureshi, Sabina Rashid
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
FRIDAY, May 29, 2020 -- Women with cancerous cells in their milk ducts -- also known as DCIS -- are at a high risk for developing fatal breast cancer, British researchers report. DCIS is short for ductal carcinoma in situ, an early form of breast...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
(NRG Oncology) The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43. The trial did find a statistically non-significant, modest (19%) reduction in the rate of recurrence among women that received trastuzumab, but this difference was not statistically significant.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Risks for invasive breast cancer, death from breast cancer higher for up to 20 years following diagnosis
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news
In conclusion, preoperatively diagnosed non-mass-type DCIS represented an underestimation in approximately 27% of cases. In particular, the presence of a clinically abnormal palpation increases the chance of upstaging to invasive cancer. PMID: 32454975 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Mol Clin Oncol Source Type: research
THURSDAY, May 28, 2020 -- Women with screening-detected ductal carcinoma in situ (DCIS) have increased long-term risks for invasive breast cancer and breast cancer death, according to a study published online May 27 in The BMJ. Gurdeep S. Mannu,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Source: BMJ - Category: General Medicine Source Type: research
Publication date: June 2020Source: Human Pathology: Case Reports, Volume 20Author(s): Tsengelmaa Jamiyan, Hajime Kuroda, Mitsuhiro Hayashi, Akihito Abe, Ken Shimizu, Yasuo Imai
Source: Human Pathology: Case Reports - Category: Pathology Source Type: research
In the five years after treatment, women with a history of ductal carcinoma...Read more on AuntMinnie.comRelated Reading: Who gets breast cancer treatment during a pandemic? Sentinel lymph node biopsy unnecessary for DCIS Does imaging modality influence DCIS recurrence? Preop breast MRI improves DCIS surgical planning
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Mastectomy | PET Scan | Radiation Therapy | Radiology | Ultrasound | Women